Jiangsu Hengrui Pharma Drives Growth with Strong R&D, BD Partnerships and Rising Profits
Jiangsu Hengrui’s latest quarterly report shows strong revenue, expanding profit margins, and a robust BD strategy that fuels its oncology pipeline and positions it for international growth.
3 minutes to read